Welcome to the British Society for Nanomedicine

With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK.

As a registered charity (Charity number 1151497) our mission includes the direct explanation of the ongoing science and commercial developments to allow the public to understand and stay in touch with this exciting area as it impacts future global healthcare. Scientists can also present their latest advances and highlight their work to industry and other researchers.

The Society is affiliated to other leading organisations involved with nanomedicine including :  CLINAM, the European Technology Platform for Nanomedicine, the British Pharmacological Society and the American Society for Nanomedicine. For these and other important partnerships see our Links page.

You are welcome to join the Society through our membership page and we would be happy to hear your comments and about ways in which you want to be involved with the BSNM.

We would also like to acknowledge initial funding to create the Society from the Engineering and Physical Sciences Research Council

The BSNM Executive Board

Professor Steve Conlan, FRSB

Chair

Professor Maya Thanou

Deputy Chair

Dr Tom McDonald

Treasurer

Dr Rachel Townsend

Secretary

Meet the Trustees

Professor Steve Conlan
Professor Steve ConlanSwansea University Medical School, Swansea University
Professor Maya Thanou
Professor Maya ThanouReader in Nanotechnology, Institute of Pharmaceutical Science, King’s College London
Dr Tom McDonald
Dr Tom McDonaldDepartment of Materials, University of Manchester
Professor Chris Scott
Professor Chris ScottSchool of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast
Dr May Azzawi
Dr May AzzawiReader; Cardiovascular Research Group; Centre for Biomedicine; Manchester Metropolitan University
Dr Christine Dufes
Dr Christine DufesSenior Lecturer, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow
Professor Gavin Jell
Professor Gavin JellProfessor in Nanotechnology & Regenerative Medicine, Faculty of Medical Sciences, University College London
Professor Lewis Francis
Professor Lewis Francis Professor of NanoBiology, Biomedical Sciences, Swansea University
Dr Marco Giardiello
Dr Marco GiardielloSenior Lecturer, Department of Chemistry, University of Liverpool
Dr Rachel Townsend
Dr Rachel TownsendMSc Programmes Manager, Swansea University
Professor Neill Liptrott
Professor Neill LiptrottProfessor in Pharmacology & Immunocompatibility, University of Liverpool
Dr Ioanna Mela
Dr Ioanna MelaFellow at Emmanuel College, University of Cambridge

Meet our Honorary Fellows

This special recognition is bestowed upon Trustees, as a heartfelt acknowledgment of longstanding and significant contributions to our Society and the field of nanomedicine as a whole.

Their dedication, leadership, and vision have played a crucial role in advancing our mission and supporting the growth of nanomedicine, leaving a lasting impact and paving the way forward.

Professor Andrew Owen
Professor Andrew OwenProfessor of Pharmacology & Therapeutics, Director of the Centre of Excellence in Long-acting Therapeutics (CELT) at the University of Liverpool.

“I’ve had the pleasure to be involved with nanomedicine research for over 15 years and during that time I have witnessed exponential growth in the field through the dedication of researchers in the UK and beyond. Nanomedicines continue to hold promise to address healthcare gaps for many diseases. Since its launch in Liverpool back in 2012, BSNM has provided a home for national and international nanomedicine research and provided a forum for knowledge sharing and new collaboration through its highly successful annual meetings. As nanomedicines continue to emerge, BSNM will remain at the forefront of science communication, and it is a real privilege to be awarded one of the first honorary fellowships of the society.”

Professor Steve Rannard
Professor Steve RannardProfessor of Chemistry, Director of the Centre of Excellence in Long-acting Therapeutics (CELT) at the University of Liverpool.

“It has been extremely exciting to have been involved in the initial planning for the creation of BSNM, followed by the inaugural meeting in 2012, and the subsequent growth of the Society. Today it truly represents nanomedicine researchers in the United Kingdom but also has reach through to a number of global nanomedicine communities. We sought to create a truly inclusive Society that celebrated our science across the whole of the UK, and this has been a core principle that still lies at the heart of BSNM today. This has been a considerable effort from a large number of contributors, and I am truly humbled to be made an honorary Fellow.”